Precision Data: Matching the Right Multimodal Data to the Right Research Question to De-risk Therapy Development
Time: 11:50 am
day: Day 1 Track B AM
Details:
- Overview of multi-modal data and its impact on therapy/CDx development, especially for trial designs (eg. eligibility, enrichment, etc), regulatory submissions, and pipeline/portfolio strategy development
- How to leverage precision multi-modal data to answer research questions and increase PTRS of therapy/CDx development programs
- Dissecting common data challenges, including incomplete patient journey (missing data points or inconsistent longitudinal data which limits understanding for disease progression and treatment response); lacks multi-modal data with depth and breadth (DNA-only or isolated panels of genes), biased data (does not represent real world population); or limitation of scale with small cohort sizes (unable to apply advanced analytical techniques)
- Collaboration and creative approaches to overcome challenges with real-world data and maximize impact to the next wave of therapeutics
